NIH Approves First Uses of HeLa Genome
By Ewen Callaway,
Nature
| 09. 17. 2013
A US National Institutes of Health (NIH) committee
approved the first uses of genomic data from the HeLa cell line on 16 September. The
HeLa Genome Data Access Working Group includes representatives of the family of Henrietta Lacks, the African American woman whose fatal cervical tumour gave rise to the HeLa cell line in 1951.
The announcement follows several months of negotiations between Lacks family members and NIH leadership, including director Francis Collins. The talks resulted in an agreement in which researchers must seek permission to use HeLa genome data generated by independent teams at the University of Washington in Seattle and the European Molecular Biology Lab in Heidelberg, Germany (see ‘
Deal done over HeLa cell line‘).
The working group received six requests; it recommended four for approval and sought further information on the other two. Intellectual-property rights figured prominently in the decisions. The working group asks researchers to disclose any plans to develop intellectual property or commercial products from the HeLa genome data. Scientists must also agree to use the data only for biomedical research (ancestry and...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...